Abrocitinib combined with low-dose corticosteroids in the management of tattoo-related cutaneous sarcoidosis: a case report
This case suggests that low-dose corticosteroids combined with a JAK1 inhibitor such as abrocitinib may represent a treatment option for patients with sarcoidosis.
Authors
- Junzhu Xu (ORCID: https://orcid.org/0000-0002-2334-4274)
- Qingwei Geng (ORCID: https://orcid.org/0000-0003-0912-4424)
Institutions
- Third People's Hospital of Hangzhou (CN)
Publication Details
- Journal
- Journal of Dermatological Treatment
- Published
- 2025-09-04
- DOI
- https://doi.org/10.1080/09546634.2025.2556487
- Primary Topic
- Sarcoidosis and Beryllium Toxicity Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00